OSBPL9P5

Across TCGA pan-cancer cohorts, OSBPL9P5 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OSBPL9P5 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OSBPL9P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OSBPL9P5 expression acts as an unfavorable survival marker.

BLCA, HNSC, and SKCM are the cancer types where OSBPL9P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	IV	0.097	0.484	<.001	36	view →
HNSC	OS	Tertile	All	0.273	0.662	.025	27	view →
SKCM	OS	Tertile	All	0.333	0.783	.035	18	view →
LGG	OS	Tertile	All	0.573	0.911	.010	18	view →
LIHC	DFS	Tertile	All	0.097	0.543	.033	18	view →
SARC	OS	Tertile	All	0.127	0.860	<.001	15	view →
BRCA	OS	Tertile	III,IV	0.127	0.547	.049	9	view →
UCEC	DFS	Tertile	All	0.772	0.899	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OSBPL9P5–BLCA (DFS)

Open the BLCA breakdown →